ZANTAC - 0173-0362-38 - (ranitidine hydrochloride)

Alphabetical Index


Drug Information of ZANTAC

Product NDC: 0173-0362
Proprietary Name: ZANTAC
Non Proprietary Name: ranitidine hydrochloride
Active Ingredient(s): 25    mg/mL & nbsp;   ranitidine hydrochloride
Administration Route(s): INTRAMUSCULAR; INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of ZANTAC

Product NDC: 0173-0362
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA019090
Marketing Category: NDA
Start Marketing Date: 19891001

Package Information of ZANTAC

Package NDC: 0173-0362-38
Package Description: 10 VIAL in 1 CARTON (0173-0362-38) > 2 mL in 1 VIAL

NDC Information of ZANTAC

NDC Code 0173-0362-38
Proprietary Name ZANTAC
Package Description 10 VIAL in 1 CARTON (0173-0362-38) > 2 mL in 1 VIAL
Product NDC 0173-0362
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name ranitidine hydrochloride
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAMUSCULAR; INTRAVENOUS
Start Marketing Date 19891001
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name RANITIDINE HYDROCHLORIDE
Strength Number 25
Strength Unit mg/mL
Pharmaceutical Classes Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]

Complete Information of ZANTAC


General Information